胰腺癌精准医学治疗模式的实践与探索_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

徐近 , 吉顺荣 ,  虞先濬

复旦大学附属肿瘤医院胰腺外科复旦大学上海医学院肿瘤学系复旦大学胰腺肿瘤研究所（上海 200032）;

Corresponding author：

虞先濬, Email: yuxianjun@fudanpci.org

Keywords：

DOI：

10.7507/1007-9424.201704051

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 徐近, 吉顺荣, 虞先濬. 胰腺癌精准医学治疗模式的实践与探索. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2017, 24(6): 668-670. doi: 10.7507/1007-9424.201704051 Copy

1.	乔海泉. Whipple 手术胰瘘的探索与思考. 中华普通外科学文献(电子版), 2015, 9(3): 179-181.
2.	Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase Ⅲ trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol, 2007, 25(15): 1960-1966.
3.	Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 2015, 518(7540): 495-501.
4.	Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 2016, 531(7592): 47-52.
5.	Xu HX, Liu L, Xiang JF, et al. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Surgery, 2017, 161(2): 373-384.
6.	Luo G, Xiao Z, Long J, et al. CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. J Gastrointest Surg, 2013, 17(12): 2092-2098.
7.	Liu L, Xu HX, Wang WQ, et al. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget, 2016, 7(5): 5943-5956.
8.	Liu L, Xu H, Wang W, et al. A preoperative serum signature of CEA⁺/CA125⁺/CA19-9≥1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. Int J Cancer, 2015, 136(9): 2216-2227.
9.	Luo G, Liu C, Guo M, et al. Potential biomarkers in Lewis negative patients with pancreatic cancer. Ann Surg, 2017, 265(4): 800-805.
10.	Luo G, Liu C, Guo M, et al. CA19-9-low&Lewis(+) pancreatic cancer: a unique subtype. Cancer Lett, 2017, 385: 46-50.

1. 乔海泉. Whipple 手术胰瘘的探索与思考. 中华普通外科学文献(电子版), 2015, 9(3): 179-181.
2. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase Ⅲ trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol, 2007, 25(15): 1960-1966.
3. Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 2015, 518(7540): 495-501.
4. Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 2016, 531(7592): 47-52.
5. Xu HX, Liu L, Xiang JF, et al. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Surgery, 2017, 161(2): 373-384.
6. Luo G, Xiao Z, Long J, et al. CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. J Gastrointest Surg, 2013, 17(12): 2092-2098.
7. Liu L, Xu HX, Wang WQ, et al. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget, 2016, 7(5): 5943-5956.
8. Liu L, Xu H, Wang W, et al. A preoperative serum signature of CEA⁺/CA125⁺/CA19-9≥1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. Int J Cancer, 2015, 136(9): 2216-2227.
9. Luo G, Liu C, Guo M, et al. Potential biomarkers in Lewis negative patients with pancreatic cancer. Ann Surg, 2017, 265(4): 800-805.
10. Luo G, Liu C, Guo M, et al. CA19-9-low&Lewis(+) pancreatic cancer: a unique subtype. Cancer Lett, 2017, 385: 46-50.

Previous Article
多学科诊疗模式在胰腺癌综合诊治决策中的价值
Next Article
The expression and significance of Beclin-1 in pancreatic ductal adenocarcinoma

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

胰腺癌精准医学治疗模式的实践与探索

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content